Peter Mugyenyi

He attended Kings College Budo, a mixed, boarding secondary school, before he was admitted to Makerere University to study human medicine.

[3] He was one of the first prominent figures in the global medical community to argue that Africans could, and would, successfully follow antiretroviral treatment regimens.

[citation needed] This action led virtually overnight to a tenfold increase in the number of people on ARVs in Uganda, and effectively ended the blockade of low-cost generic AIDS drugs into Africa.

PEPFAR has since put millions of Africans on lifesaving antiretroviral treatment, and is widely viewed as by far the single most positive legacy of George W. Bush's two terms in the White House.

[3] In September 2003, Mugyenyi was honored by the International Association of Physicians in AIDS Care and presented with the Hero in Medicine Award.

[4] In February 2014, he was appointed as an independent Director, to the Board of Cipla, the Indian pharmaceutical company with an ARV manufacturing factory in Uganda.